EMA Works On Defining Metadata From RWD Sources

As part of its big data initiative, the European Medicines Agency is supporting projects that will help identify appropriate real-world data sources for regulatory decision making.

Big data
Medicines regulators will increasingly use insights derived from big data to assess drugs • Source: Shutterstock

The European Medicines Agency is looking at ways to strengthen the use of real-world data (RWD) in medicines development by promoting data discoverability through the identification of metadata.

Metadata is a term that refers to data that provides information about other data. Metadata for a document, for example, might include information on its author, file size, key words,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography